Systemic therapy for locally advanced and metastatic non–small cell lung cancer: a review

KC Arbour, GJ Riely - Jama, 2019 - jamanetwork.com
Importance Non–small cell lung cancer remains the leading cause of cancer death in the
United States. Until the last decade, the 5-year overall survival rate for patients with …
被引用次数：937 相关文章

Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review

KC Arbour, GJ Riely - JAMA, 2019 - pubmed.ncbi.nlm.nih.gov
Importance Non-small cell lung cancer remains the leading cause of cancer death in the
United States. Until the last decade, the 5-year overall survival rate for patients with …

Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.

KC Arbour, GJ Riely - JAMA, 2019 - europepmc.org
Non-small cell lung cancer remains the leading cause of cancer death in the United States.
Until the last decade, the 5-year overall survival rate for patients with metastatic non-small …

[引用][C] Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

KC Arbour, GJ Riely - JAMA, 2019 - cir.nii.ac.jp
Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

[引用][C] Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer A Review

KC Arbour, GJ Riely - JAMA, 2019